Donna Ambrosino
Vermogen: 68 129 $ op 30-06-2026
Vermogen: 68 129 $ op 30-06-2026
Donna Marie Ambrosino currently works at Clover Biopharmaceuticals Ltd., as Non-Executive Director from 2022.
Dr. Ambrosino also formerly worked at Visterra, Inc., as Chief Medical Officer from 2012 to 2014 and Harvard Medical School, as Associate Professor.
Dr. Ambrosino received her undergraduate degree from Harvard University and doctorate degree from Dartmouth Medical School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 329.796 ( 0,03% ) | 68 129 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Bestuurslid | 17-06-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VISTERRA INC | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Visterra, Inc.
Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau